BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Director Sells $1,632,400.00 in Stock

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) Director Jean Jacques Bienaime sold 20,000 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $81.62, for a total transaction of $1,632,400.00. Following the transaction, the director now owns 474,994 shares in the company, valued […]

Related Keywords

Jean Jacques Bienaime ,Robertw Baird ,Piper Sandler ,Biomarin Pharmaceutical Inc ,Avoro Capital Advisors ,Capital Research Global Investors ,Nasdaq ,Canaccord Genuity Group ,Ameriprise Financial Inc ,Morgan Stanley ,Vanguard Group Inc ,Biomarin Pharmaceutical Company Profile ,Barclays Plc ,Biomarin Pharmaceutical ,Get Free Report ,Director Jean Jacques Bienaime ,Jacques Bienaime ,Marin Pharmaceutical ,Research Global Investors ,Capital Advisors ,Genuity Group ,Marin Pharmaceutical Inc ,Biomarin Pharmaceutical Daily ,